The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Phase 3 ELOQUENT-2 study: Extended four year follow-up (FU) of elotuzumab plus lenalidomide/dexamethasone (ELd) vs Ld in relapsed/refractory multiple myeloma (RRMM).
 
Sagar Lonial
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen Oncology; Millennium; Novartis; Onyx; Sanofi
 
Meletios A. Dimopoulos
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Genesis Pharmaceuticals; Janssen-Cilag; Novartis; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen-Cilag; Takeda
Research Funding - Amgen (Inst); Janssen-Cilag (Inst)
Travel, Accommodations, Expenses - Amgen; Genesis Pharmaceuticals; Janssen-Ortho
 
Katja C. Weisel
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Onyx; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Onyx; Takeda
Research Funding - Amgen; Celgene; Janssen; Sanofi
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Takeda
 
Darrell White
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Janssen (Inst); Takeda (Inst)
 
Philippe Moreau
Honoraria - Amgen; Celgene; Janssen-Cilag; Novartis; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen; Novartis; Takeda
 
Maria-Victoria Mateos
Honoraria - Amgen; Celgene; Janssen-Cilag; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen-Cilag; Takeda
 
Jesus San Miguel
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; MSD; Novartis; Takeda
 
Kenneth Carl Anderson
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Gilead Sciences; Millennium
Patents, Royalties, Other Intellectual Property - Acetylon Pharmaceuticals; C4 Therapeutics; Oncopep
 
Ofer Shpilberg
Consulting or Advisory Role - Gilead Sciences; Millennium; Takeda
 
Sebastian Grosicki
No Relationships to Disclose
 
Ivan Spicka
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Speakers' Bureau - Amgen; Celgene; Janssen
Research Funding - Celgene
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene
 
Adam Walter-Croneck
Honoraria - Merck Sharp & Dohme
Consulting or Advisory Role - Janssen-Cilag
Research Funding - Bristol-Myers Squibb
 
Hila Magen
No Relationships to Disclose
 
Andrew Belch
Research Funding - Bristol-Myers Squibb
 
Donna Ellen Reece
Honoraria - Amgen; Celgene; Janssen; Lundbeck; Novartis
Consulting or Advisory Role - Celgene; Janssen; Onyx
Research Funding - Bristol-Myers Squibb; Celgene; Janssen; Merck; Millennium; Novartis; Otsuka; Takeda
 
Meral Beksac
Honoraria - Bristol-Myers Squibb; Celgene; Janssen-Cilag; Novartis; Takeda
Consulting or Advisory Role - Celgene; Janssen-Cilag; Takeda
Speakers' Bureau - Bristol-Myers Squibb; Celgene; Janssen-Cilag
 
Sabeen Mekan
No Relationships to Disclose
 
Oumar Sy
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Anil K. Singhal
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Paul G. Richardson
Consulting or Advisory Role - Genmab
Research Funding - Celgene; Millennium